This potential is hindered by a challenge of maintaining blood glucose within range with insulin therapy, that is especially demanding for persons with type 1 diabetes, who often do not achieve appropriate chronic glucose control (McCarthy et al., 2016). Here, INS is linked to type 1 diabetes mellitus.